ARCT — Arcturus Therapeutics Holdings Balance Sheet
0.000.00%
- $350.12m
- $113.09m
- $152.31m
- 33
- 35
- 38
- 27
Annual balance sheet for Arcturus Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 463 | 370 | 392 | 292 | 237 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.13 | 3.37 | 2.76 | 32.1 | 3.97 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 468 | 379 | 403 | 387 | 306 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.56 | 11.3 | 45 | 40.9 | 36.2 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 476 | 393 | 450 | 429 | 344 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 49.5 | 99.5 | 127 | 82 | 65.5 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 79.9 | 165 | 180 | 151 | 103 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 397 | 228 | 270 | 279 | 241 |
Total Liabilities & Shareholders' Equity | 476 | 393 | 450 | 429 | 344 |
Total Common Shares Outstanding |